NCI-H1648 [H1648]

NCI-H1648 [H1648]

收藏
  • 询价
  • 2025年09月22日
    avatar
    14金牌会员
  • 企业认证

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 技术资料
    • 运输方式

      冻存运输

    • 相关疾病

      腺癌

    • ATCC Number

      CRL-5882™

    • 年限

      stage 3A

    • 器官来源

    • 库存

      大量

    • 物种来源

    • 是否是肿瘤细胞

      0

    • 生长状态

      贴壁生长

    Designations: NCI-H1648 [H1648]
    Depositors:  AF Gazdar, JD Minna
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: adherent
    Organism: Homo sapiens
    Morphology:
    Source: Organ: lung
    Tumor Stage: stage 3A
    Disease: adenocarcinoma
    Derived from metastatic site: lymph node
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Restrictions: The line is available with the following restrictions: 1. This cell line was deposited at the ATCC by Dr. A. Gazdar and Dr. J. Minna and is provided for research purposes only. Neither the cell line nor products derived from it may be sold or used for commercial purposes. Nor can the cells be distributed to third parties for purposes of sale, or producing for sale, cells or their products. The cells are provided as service to the research community. They are provided without warranty of merchantability or fitness for a particular purpose or any other warranty, expressed or implied. 2. Any proposed commercial use of the these cells, or their products must first be negotiated with the University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, Texas 75235. Telephone (214) 699-8056, FAX (214) 688-7233.
    DNA Profile (STR): Amelogenin: X,Y
    CSF1PO: 10,12
    D13S317: 12
    D16S539: 11
    D5S818: 11
    D7S820: 10,11
    THO1: 7,9.3
    TPOX: 8,11
    vWA: 14,17
    Age: 39 years
    Gender: male
    Ethnicity: Black
    Comments: The line was established in May 1987.
    The patient was a smoker.
    40 pack years.
    A lymphoblastoid line from the same patient is available as ATCC CRL-5954.
    Propagation: ATCC complete growth medium: ACL-4 medium (serum-free)
    The base medium for this cell line is ATCC formulated :DMEM: F12 Medium Catalog No. 30-2006. To make the complete growth medium, add the following components to the base medium:
  • 0.02 mg/ml insulin
  • 0.01 mg/ml transferrin
  • 25 nM sodium selenite (final conc.)
  • 50 nM Hydrocortisone (final conc.)
  • 1 ng/ml Epidermal Growth Factor (do not filter)
  • 0.01 mM ethanolamine (final conc.)
  • 0.01 mM phosphorylethanolamine (final conc.)
  • 100 pM triiodothyronine (final conc.)
  • 0.5% (w/v) bovine serum albumin (final conc.)
  • 10 mM HEPES (final conc.)
  • 0.5 mM sodium pyruvate (final conc.)
  • extra 2mM L-glutamine (for final conc. of 4.5mM)
  • Subculturing: Protocol: Volumes used in this protocol are for 75 sq cm flasks; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes.
    • Remove and discard culture medium.
    • Briefly rinse the cell layer with Ca++/Mg++ free Dulbecco's phosphate-buffered saline (D-PBS) or 0.25% (w/v) Trypsin - 0.53 mM EDTA solution .
    • Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
      Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37C to facilitate dispersal.
    • Add 2.0 to 3.0 ml of complete growth medium and aspirate cells by gently pipetting.Transfer cell suspension to a centrifuge tube and spin at approximately 125 X g for 5 to 10 minutes. Discard supernatant.
    • Resuspend the cell pellet in fresh growth medium. Add appropriate aliquots of the cell suspension to new culture vessels.
    • Incubate cultures at 37C.

    Subcultivation Ratio: Subcultivation Ratio: 1:3 to 1:6
    Preservation: Culture medium, 95%; DMSO, 5%
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2006
    normal (or near-normal) cell line established from the same patient:ATCC CRL-5954
    References: 23570: . NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996..

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥500
    北京百奥创新科技有限公司
    2025年07月06日询价
    ¥1800
    博辉生物科技(广州)有限公司
    2025年12月19日询价
    ¥798
    诺安基因科技(武汉)有限公司
    2025年07月12日询价
    询价
    上海彩佑实业有限公司
    2025年05月20日询价
    询价
    上海雅吉生物科技有限公司
    2025年05月13日询价
    NCI-H1648 [H1648]
    询价